CAD4TB: Artificial Iintelligence for Tuberculosis Detection Globally

ThironaIs it possible to screen thousands of people for tuberculosis using artificial intelligence in a country where internet barely exists? It is with CAD4TB. As of October, this innovative software is used to screen people for TB in even the remotest areas of Eritrea. It has been developed by Dutch company Thirona in collaboration with the also Dutch Delft Imaging Systems. CAD4TB is the most validated and widely used artificial intelligence solution for TB-detection worldwide. Every day, it is used to screen 7.000 people for this disease that kills 1.6 million people a year - that is more than die from AIDS and malaria combined.

TB tracked down

The Eritrean Ministry of Health gives high priority to the elimination of deadly diseases, but the local infrastructure is largely underdeveloped and internet is scarcely available. It makes TB-screening challenging and time-consuming. Computer-Aided Detection for Tuberculosis (CAD4TB) is a software programme that analyses digital chest x-rays. In situations with a working internet connection, the chest image is analysed by the CAD4TB server in the cloud. In places where an internet connection is not available or not reliable, images can be analysed directly on-site. With this portable solution, TB can be tracked down and treated anywhere.

Virtual doctor

Guido Geerts, CEO of Thirona, about the necessity of implementing artificial intelligence in combating TB in Eritrea: "In Eritrea, only 1% of the population has access to the internet, radiologists are scarce and large parts of the country are extremely difficult to reach. The big advantage of CAD4TB is the option to use it completely offline, so we can professionally screen people even in the most remote areas. Within twenty seconds the x-ray image is analysed and the likelihood of someone having TB determined. It is a virtual doctor that has scientifically been proven to be more accurate than an expert human reader."

For further information, please visit:
http://www.thirona.eu

About Thirona

Thirona is an innovative Dutch company specialised in artificial intelligence for medical image analysis. By creating intuitive and user-friendly products, it bridges the gap between academic ideas and clinical use. Thirona supports medical professionals in their daily tasks working with thoracic CT-scans (LungQ), chest x-rays (CAD4TB) and retinal scans (RetCAD). Thirona was established in 2014 and has grown out to be an important player in the medical field with innovative AI-solutions used in over forty countries worldwide.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...